Amgen says its experimental drug helped patients lose 20% of weight, Wall Street is not impressed ...Middle East

Quartz - Economy
Amgen says its experimental drug helped patients lose 20% of weight, Wall Street is not impressed
Amgen (AMGN) reported today the highly anticipated results of a mid-stage trial of its experimental weight-loss drug and potential Ozempic competitor MariTide, however, Wall Street wasn’t very impressed.Read more...

Hence then, the article about amgen says its experimental drug helped patients lose 20 of weight wall street is not impressed was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Amgen says its experimental drug helped patients lose 20% of weight, Wall Street is not impressed )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News